Maryalice Stetler-Stevenson Selected Research

Maryalice Stetler-Stevenson Research Topics

Disease

27	Neoplasms (Cancer) 11/2020 - 12/2003
16	Hairy Cell Leukemia 12/2021 - 05/2006
15	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 03/2010
15	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 06/2003
11	Multiple Myeloma 11/2021 - 02/2005
10	Residual Neoplasm 01/2022 - 05/2006
9	Lymphoma (Lymphomas) 09/2019 - 02/2005
6	Smoldering Multiple Myeloma 11/2021 - 06/2014
5	Leukemia 01/2022 - 01/2016
5	Disease Progression 01/2018 - 09/2005
5	Hemolytic-Uremic Syndrome 10/2017 - 09/2005
5	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2017 - 04/2009
4	Lymphocytosis 01/2021 - 09/2002
3	Hematologic Neoplasms (Hematological Malignancy) 10/2018 - 03/2010
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 07/2014
3	Hypoalbuminemia 10/2017 - 09/2005
3	B-Cell Lymphoma (Lymphoma, B Cell) 02/2015 - 02/2005
2	Thrombocytopenia (Thrombopenia) 01/2023 - 10/2020
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 12/2021 - 10/2020
2	Circulating Neoplastic Cells 04/2016 - 12/2011
2	Infections 11/2015 - 06/2009
2	Burkitt Lymphoma (Burkitt's Lymphoma) 07/2014 - 02/2005
2	Fatigue 05/2012 - 09/2005
2	Edema (Dropsy) 05/2012 - 09/2005
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2011 - 09/2005
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2010 - 01/2008
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2009 - 04/2009
2	T-Cell Lymphoma (Lymphoma, T Cell) 11/2009 - 04/2009
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2009 - 03/2009
1	Cytokine Release Syndrome 12/2021
1	Neutropenia 12/2021
1	Hyperferritinemia 12/2021
1	Hyperbilirubinemia 12/2021
1	Hypertriglyceridemia 12/2021
1	Primary Effusion Lymphoma 01/2021
1	Multi-centric Castleman's Disease 01/2021
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2021
1	Hemorrhage 10/2020
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019
1	Cardiotoxicity 11/2018
1	Monoclonal Gammopathy of Undetermined Significance 01/2018
1	Mesothelioma 01/2018
1	Aspergillosis 12/2017
1	Thrombotic Microangiopathies 10/2017
1	Capillary Leak Syndrome 10/2017
1	Weight Gain 10/2017

Drug/Important Bio-Agent (IBA)

18	Chimeric Antigen ReceptorsIBA 01/2023 - 11/2010
9	AntigensIBA 01/2022 - 09/2005
9	Immunotoxins (Immunotoxin)IBA 10/2018 - 09/2005
8	ibrutinibIBA 11/2020 - 02/2015
7	Rituximab (Mabthera)FDA Link 12/2021 - 09/2002
6	Cladribine FDA LinkGeneric 12/2021 - 05/2006
6	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 09/2015
6	Lenalidomide (CC 5013)FDA Link 11/2021 - 09/2015
5	carfilzomibIBA 11/2021 - 09/2015
4	purineIBA 12/2021 - 12/2013
4	immunotoxin HA22IBA 01/2018 - 06/2011
3	CytokinesIBA 01/2023 - 03/2012
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 04/2016
3	B-Cell Maturation AntigenIBA 01/2018 - 01/2016
3	Transaminases (Aminotransferases)IBA 10/2017 - 09/2005
3	Alemtuzumab (Campath)FDA Link 01/2017 - 04/2009
3	Proteins (Proteins, Gene)FDA Link 02/2012 - 12/2003
3	Tissue Inhibitor of Metalloproteinase-1IBA 09/2008 - 12/2004
2	CD19 AntigensIBA 01/2022 - 11/2010
2	fludarabineIBA 11/2020 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	Inotuzumab OzogamicinIBA 04/2019 - 01/2019
2	B3(Fv)-PE38KDEL recombinant immunotoxinIBA 01/2016 - 06/2011
2	AntibodiesIBA 01/2016 - 02/2012
2	Monoclonal AntibodiesIBA 01/2016 - 04/2009
2	Immunoglobulin M (IgM)IBA 06/2014 - 01/2011
2	Bendamustine Hydrochloride FDA Link 11/2013 - 06/2011
2	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 04/2010 - 09/2005
2	Interleukin-7 (Interleukin 7)IBA 01/2010 - 05/2006
1	blinatumomabIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021
1	ofatumumab FDA Link 01/2021
1	avelumabIBA 01/2021
1	Interleukin-13IBA 01/2021
1	serum P-component (CIt)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2020
1	AnnexinsIBA 01/2020
1	Tartrate-Resistant Acid PhosphataseIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	Immunomodulating AgentsIBA 01/2017
1	CaspasesIBA 01/2017

Therapy/Procedure

29	Therapeutics 11/2021 - 09/2005
9	Drug Therapy (Chemotherapy) 10/2017 - 09/2005
4	Immunotherapy 10/2020 - 01/2008
2	Hematopoietic Stem Cell Transplantation 01/2019 - 09/2012
2	Plasmapheresis 06/2009 - 09/2005
1	Radiotherapy 01/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2020